WHO and India Unite to Bring Ayush into Global Health Fold

In a landmark development for India’s traditional medicine sector, the Ministry of Ayush has entered into a formal partnership with the World Health Organisation (WHO) to integrate Ayush practices into the global healthcare system...

NABL Pushes Accredited Labs to Use Combined ILAC MRA Mark for Global Trust

The National Accreditation Board for Testing and Calibration Laboratories (NABL) is encouraging its accredited Conformity Assessment Bodies

Divi's Labs Signs Long-term Pact to Supply Advanced Intermediates

Divi's Laboratories Limited has entered into a long-term manufacturing and supply agreement with a leading global pharmaceuticals company to manufacture and supply advanced intermediates that...

NABH Cracks Down on Fake Docs: Hospitals under Scrutiny

The National Accreditation Board for Hospitals and Healthcare Providers (NABH) has restated its zero-tolerance policy

Steriline debuts agile, flexible filler at Pharmintech 2025

Steriline, a company highly specialised in the production of complete aseptic packaging lines for injectables and ophthalmic products for global pharmaceutical companies, will participate...

Meril Presents Successful LANDMARK RCT One-Year Results at Prestigious EuroPCR 2025

Meril Life Sciences today announced one-year results from its pivotal LANDMARK trial, presented during the prestigious Late-Breaking Trial session at EuroPCR 2025, one of the world’s premier cardiology conferences held annually in Paris, France.

Lupin Licenses Biosimilar Ranibizumab for Latin American Markets

Lupin pharmaceutical announced that it has entered into a license and supply agreement with SteinCares for the commercialization of biosimilar ranibizumab throughout all of Latin America...

Syngene Targets Brain Biomarker to Boost Anxiety Drug Research

In the developing side of drug development for mood and anxiety disorders, Syngene has stressed the critical need to precisely measure

Dr Reddy's API Unit in Telangana Gets 2 USFDA Observations

After a close inspection of its active pharmaceutical ingredient (API) manufacturing unit, Dr. Reddy’s Laboratories has received a Form 483 with two observations from the US Food and Drug Administration (USFDA)...

XTANDI Extends Survival in Metastatic Hormone-Sensitive Prostate Cancer

Astellas Pharma and Pfizer have reported new updated long-term results from the open-label extension portion of the Phase 3 ARCHES study that utilized a five-year follow-up to demonstrate continued overall survival (OS) benefits...

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.